VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 130 participants.

Also called NCT06384599

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06384599
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06384599. Allocation not applicable; no masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2027-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
Condition
Ventricular Tachycardia
Intervention (Device)
VT Cryoablation System
Lead sponsor
Adagio Medical (class: industry)

Record details

Record id
cardio:ct-nct06384599
Content hash
b3203073d2e0225e917f7b9b273b2c60d10f51e12a4d088b47295dc1f517098b